Corteva (CTVA) director Policinski receives 2,350-share stock grant

Rhea-AI Filing Summary

Policinski Christopher J. reported acquisition or exercise transactions in this Form 4 filing.

Corteva, Inc. director Christopher J. Policinski received a grant of 2,350 shares of Corteva common stock on April 28, 2026. The shares were awarded at a stated price of $0.0000 per share, indicating a compensation-related grant rather than a market purchase. After this award, he directly owns 2,350 Corteva common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Policinski Christopher J.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,350	$0.00	--

Holdings After Transaction: Common Stock — 2,350 shares (Direct, null)

Footnotes (1)

Key Figures

Shares granted: 2,350 shares Price per share: $0.0000 per share Total shares after grant: 2,350 shares

3 metrics

Shares granted 2,350 shares Non-derivative common stock grant on April 28, 2026

Price per share $0.0000 per share Stated transaction price for granted shares

Total shares after grant 2,350 shares Direct ownership following the reported transaction

Key Terms

Common Stock, non-derivative, Grant, award, or other acquisition

3 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

"transaction_type: "non-derivative""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Policinski Christopher J.

(Last) (First) (Middle)

C/O CORTEVA, INC.

9330 ZIONSVILLE ROAD

(Street)

INDIANAPOLIS INDIANA 46268

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Corteva, Inc. [ CTVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/28/2026		A		2,350	A	$0	2,350	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/Abigail Jarrell, by power-of-attorney	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Corteva (CTVA) director Christopher J. Policinski report on this Form 4?

Christopher J. Policinski reported receiving a grant of 2,350 shares of Corteva common stock. The transaction is coded as a grant, award, or other acquisition, reflecting equity compensation rather than an open-market trade, and resulted in direct ownership of 2,350 shares.

How many Corteva (CTVA) shares did Christopher J. Policinski acquire in the latest Form 4?

He acquired 2,350 shares of Corteva common stock. The filing shows this as a non-derivative transaction, increasing his direct holdings to 2,350 shares following the grant. No purchase price was paid, consistent with a stock award for compensation.

What type of transaction is reported in Corteva (CTVA) director Policinski’s Form 4?

The transaction is a “Grant, award, or other acquisition” of common stock. It is classified as a non-derivative acquisition with transaction code A, indicating stock granted as compensation rather than an open-market buy or sell by the director.

What is Christopher J. Policinski’s Corteva (CTVA) share ownership after this reported grant?

After the reported transaction, he directly owns 2,350 shares of Corteva common stock. The Form 4 lists these 2,350 shares as his total non-derivative holdings following the grant award, all held under direct ownership rather than through an intermediary entity.

Was cash paid for the Corteva (CTVA) shares granted to Christopher J. Policinski?

The Form 4 reports a transaction price of $0.0000 per share for the 2,350 Corteva shares. This indicates the shares were granted at no cash cost to him, consistent with a typical equity compensation award rather than a market purchase transaction.